Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis

Ettore Beghi, Andrea Millul, Giancarlo Logroscino, Eugenio Vitelli, Anna Micheli

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The purpose of the study was to assess frequency and predictors of disability measures in ALS. One hundred and fourteen newly diagnosed patients resident in eight administrative districts of Lombardy, Italy (population 4,947,554), included in a population-based registry, were followed for 2570 person-months (mean 22.5 months). The cumulative time-dependent risk of wheelchair, percutaneous endoscopic gastrostomy, and assisted ventilation was estimated according to the Kaplan-Meier method. Predictors of disability (age, sex, disease duration at diagnosis, type of onset, El-Escorial diagnosis) were assessed with the Cox proportional hazard function. During follow-up, 29 patients (25.4%) became wheelchair bound, 51 (44.7%) received gastrostomy, and 47 (41.2%) received assisted ventilation. The median time to loss of ambulation was 46.7 months (95% CI 36.5-56.8). The median time to gastrostomy and assisted ventilation was 31.1 months (95% CI 26.8-35.4) and 34.6 months (95% CI 29.6-39.6), respectively. Spinal onset ALS was the only predictor of loss of ambulation. Predictors of gastrostomy were older age, definite ALS, and shorter disease duration. Shorter disease duration was the only predictor of assisted ventilation. In conclusion, patients with ALS differ in terms of measures and predictors of disability. These factors are sources of bias and confounding in randomized clinical trials.

Original languageEnglish
Pages (from-to)163-167
Number of pages5
JournalAmyotrophic Lateral Sclerosis
Volume9
Issue number3
DOIs
Publication statusPublished - 2008

Fingerprint

Gastrostomy
Amyotrophic Lateral Sclerosis
Ventilation
Outcome Assessment (Health Care)
Wheelchairs
Walking
Italy
Population
Registries
Randomized Controlled Trials

Keywords

  • Ambulation
  • Amyotrophic lateral sclerosis
  • Assisted ventilation
  • Gastrostomy
  • Prognosis

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis. / Beghi, Ettore; Millul, Andrea; Logroscino, Giancarlo; Vitelli, Eugenio; Micheli, Anna.

In: Amyotrophic Lateral Sclerosis, Vol. 9, No. 3, 2008, p. 163-167.

Research output: Contribution to journalArticle

Beghi, Ettore ; Millul, Andrea ; Logroscino, Giancarlo ; Vitelli, Eugenio ; Micheli, Anna. / Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis. In: Amyotrophic Lateral Sclerosis. 2008 ; Vol. 9, No. 3. pp. 163-167.
@article{73b75ea296514098bfd1cfe8aa37f7d6,
title = "Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis",
abstract = "The purpose of the study was to assess frequency and predictors of disability measures in ALS. One hundred and fourteen newly diagnosed patients resident in eight administrative districts of Lombardy, Italy (population 4,947,554), included in a population-based registry, were followed for 2570 person-months (mean 22.5 months). The cumulative time-dependent risk of wheelchair, percutaneous endoscopic gastrostomy, and assisted ventilation was estimated according to the Kaplan-Meier method. Predictors of disability (age, sex, disease duration at diagnosis, type of onset, El-Escorial diagnosis) were assessed with the Cox proportional hazard function. During follow-up, 29 patients (25.4{\%}) became wheelchair bound, 51 (44.7{\%}) received gastrostomy, and 47 (41.2{\%}) received assisted ventilation. The median time to loss of ambulation was 46.7 months (95{\%} CI 36.5-56.8). The median time to gastrostomy and assisted ventilation was 31.1 months (95{\%} CI 26.8-35.4) and 34.6 months (95{\%} CI 29.6-39.6), respectively. Spinal onset ALS was the only predictor of loss of ambulation. Predictors of gastrostomy were older age, definite ALS, and shorter disease duration. Shorter disease duration was the only predictor of assisted ventilation. In conclusion, patients with ALS differ in terms of measures and predictors of disability. These factors are sources of bias and confounding in randomized clinical trials.",
keywords = "Ambulation, Amyotrophic lateral sclerosis, Assisted ventilation, Gastrostomy, Prognosis",
author = "Ettore Beghi and Andrea Millul and Giancarlo Logroscino and Eugenio Vitelli and Anna Micheli",
year = "2008",
doi = "10.1080/17482960801942695",
language = "English",
volume = "9",
pages = "163--167",
journal = "Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders",
issn = "1466-0822",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis

AU - Beghi, Ettore

AU - Millul, Andrea

AU - Logroscino, Giancarlo

AU - Vitelli, Eugenio

AU - Micheli, Anna

PY - 2008

Y1 - 2008

N2 - The purpose of the study was to assess frequency and predictors of disability measures in ALS. One hundred and fourteen newly diagnosed patients resident in eight administrative districts of Lombardy, Italy (population 4,947,554), included in a population-based registry, were followed for 2570 person-months (mean 22.5 months). The cumulative time-dependent risk of wheelchair, percutaneous endoscopic gastrostomy, and assisted ventilation was estimated according to the Kaplan-Meier method. Predictors of disability (age, sex, disease duration at diagnosis, type of onset, El-Escorial diagnosis) were assessed with the Cox proportional hazard function. During follow-up, 29 patients (25.4%) became wheelchair bound, 51 (44.7%) received gastrostomy, and 47 (41.2%) received assisted ventilation. The median time to loss of ambulation was 46.7 months (95% CI 36.5-56.8). The median time to gastrostomy and assisted ventilation was 31.1 months (95% CI 26.8-35.4) and 34.6 months (95% CI 29.6-39.6), respectively. Spinal onset ALS was the only predictor of loss of ambulation. Predictors of gastrostomy were older age, definite ALS, and shorter disease duration. Shorter disease duration was the only predictor of assisted ventilation. In conclusion, patients with ALS differ in terms of measures and predictors of disability. These factors are sources of bias and confounding in randomized clinical trials.

AB - The purpose of the study was to assess frequency and predictors of disability measures in ALS. One hundred and fourteen newly diagnosed patients resident in eight administrative districts of Lombardy, Italy (population 4,947,554), included in a population-based registry, were followed for 2570 person-months (mean 22.5 months). The cumulative time-dependent risk of wheelchair, percutaneous endoscopic gastrostomy, and assisted ventilation was estimated according to the Kaplan-Meier method. Predictors of disability (age, sex, disease duration at diagnosis, type of onset, El-Escorial diagnosis) were assessed with the Cox proportional hazard function. During follow-up, 29 patients (25.4%) became wheelchair bound, 51 (44.7%) received gastrostomy, and 47 (41.2%) received assisted ventilation. The median time to loss of ambulation was 46.7 months (95% CI 36.5-56.8). The median time to gastrostomy and assisted ventilation was 31.1 months (95% CI 26.8-35.4) and 34.6 months (95% CI 29.6-39.6), respectively. Spinal onset ALS was the only predictor of loss of ambulation. Predictors of gastrostomy were older age, definite ALS, and shorter disease duration. Shorter disease duration was the only predictor of assisted ventilation. In conclusion, patients with ALS differ in terms of measures and predictors of disability. These factors are sources of bias and confounding in randomized clinical trials.

KW - Ambulation

KW - Amyotrophic lateral sclerosis

KW - Assisted ventilation

KW - Gastrostomy

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=47249135456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47249135456&partnerID=8YFLogxK

U2 - 10.1080/17482960801942695

DO - 10.1080/17482960801942695

M3 - Article

VL - 9

SP - 163

EP - 167

JO - Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

JF - Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

SN - 1466-0822

IS - 3

ER -